Press Release

Organizational and Personnel Changes of ASKA PharmaceuticalTOKYO, August 26, 2022 - ASKA Pharmaceutical Holdings Co., Ltd. (Headquarters: Minatoku, Tokyo/ President, Representative Director: Takashi Yamaguchi, hereinafter “ASKA”)
announced the following organizational and personnel changes of its subsidiary, ASKA
Pharmaceutical Co., Ltd., effective October 1, 2022, respectively.
1. Organizational Change
To reinforce the monitoring system for sales information provision activities, a new department
independent from each division will be established.
The “Sales Information Provision Supervisory Team” of Quality & Safety Assurance
Division will be renamed the “Information service Supervisory Unit” and will become an
independent organization.

2. Change of Corporate Officer’s Responsibilities.
[New Responsibilities]
Corporate Officer, Director of Information service Supervisory Unit
(Corporate Officer, In Charge of Audit and Legal Affairs & Regulatory
Kunihiro Gunji

Compliance of ASKA Pharmaceutical Holdings Co., Ltd.)[Current Responsibilities]
Administrative Division * Seconded to ASKA Pharmaceutical Holdings Co., Ltd.
(Corporate Officer, In Charge of Audit and Legal Affairs & Regulatory
Compliance of ASKA Pharmaceutical Holdings Co., Ltd.)

3. Personnel Appointments[New Responsibilities]
Assistant Division Director of Innovative Drug Discovery Division(Concurrently works in Portfolio Management Department)
Yasuhiro Tsukimi[Current Responsibilities]
Assistant Division Director of Innovative Drug Discovery Division
Director of Drug Discovery Department(Concurrently works in Portfolio Management Department)[New Responsibilities]
Assistant Division Director of Production Division

Kazuhiro Sasaki

Director of Pharmaceutical Technology Department[Current Responsibilities]
Director of Pharmaceutical Technology Department, Production Division

1/2

[New Responsibilities]
Director of Drug Discovery Department, Innovative Drug Discovery Division
MasayukiYoshizawa* concurrently continues as Manager of Drug Discovery Department[Current Responsibilities]
Manager of Drug Discovery Department, Innovative Drug Discovery
Division[New Responsibilities]
Director of Quality Assurance Department, Quality & Safety Assurance

Kenichi Tajima

Division * Quality Assurance Manager[Current Responsibilities]
Manager of Quality Assurance Department, Quality & Safety Assurance
Division[New Responsibilities]

Chiaki Neuchi

Director of Quality Control Department, Iwaki Factory, Production Division[Current Responsibilities]
Manager of Manufacturing Department, Iwaki Factory, Production Division[New Responsibilities]
Director of North Japan Sales Department, Sales Division

Takashi Ishimori[Current Responsibilities]
Manager of Sapporo Sales Office, North Japan Sales Department, SalesDivision[New Responsibilities]

Akira Hasegawa

Director of West Japan Sales Department Region 2, Sales Division[Current Responsibilities]
Director of East Japan Sales Department Region 2, Sales Division[New Responsibilities]
Director of East Japan Sales Department Region 2, Sales Division

Takeshi Okoshi[Current Responsibilities]
Manager of Saitama Sales Office, East Japan Sales Department Region 2,Sales Division

Media Contacts

ASKA Pharmaceutical Holdings Co., Ltd.
Corporate Planning Department
Tel: +81-3-5484-8366
Email: kouhou@aska-pharma.co.jp

2/2